日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

纳米医学驱动的肿瘤葡萄糖代谢重编程以增强癌症免疫疗法

Jiang, Chenwei; Tang, Minglu; Su, Yun; Xie, Junjie; Shang, Qi; Guo, Mingmei; An, Xiaoran; Lin, Longfei; Wang, Ruibin; Huang, Qian; Zhang, Guangji; Li, Hui; Wang, Feihu

Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma

鉴定 FOXP1 为肝内胆管癌的良好预后生物标志物和肿瘤抑制因子

Chenwei Tang #, Hongkai Zhuang #, Huanjun Tong, Xiaopeng Yu, Jialu Chen, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Yonglin Hua, Changzhen Shang, Zhaohui Tang

CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export

CircRNA MBOAT2 通过稳定 PTBP1 促进 FASN mRNA 胞质输出,从而促进肝内胆管癌进展和脂质代谢重编程

Xiaopeng Yu, Huanjun Tong, Jialu Chen, Chenwei Tang, Shuqing Wang, Yu Si, Shouhua Wang, Zhaohui Tang

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma

鉴定新的铁死亡相关基因特征以预测肝细胞癌的预后和对免疫治疗的反应性

Qingbin Wang #, Bingkun Wang #, Xiaowu Ma, Hongkai Zhuang, Zhiqin Xie, Chenwei Tang, Wenliang Tan, Lei Yang, Changzhen Shang, Yajin Chen

GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA

GEPIA2021:将多种基于反卷积的分析集成到 GEPIA 中

Li, Chenwei; Tang, Zefang; Zhang, Wenjie; Ye, Zhaochen; Liu, Fenglin